268 related articles for article (PubMed ID: 28946191)
1. TMEM88 inhibits extracellular matrix expression in keloid fibroblasts.
Zhao H; Lu F; Cui S; Zhang X; Wang W; Si E; Yuan Z
Biomed Pharmacother; 2017 Nov; 95():1436-1440. PubMed ID: 28946191
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of IRF3 inhibits extracellular matrix expression in keloid fibroblasts.
Zhang Y; Zhang L; Lin XH; Li ZM; Zhang QY
Biomed Pharmacother; 2017 Apr; 88():1064-1068. PubMed ID: 28192879
[TBL] [Abstract][Full Text] [Related]
3. Silencing NLRC5 inhibits extracellular matrix expression in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.
Ma HL; Zhao XF; Chen GZ; Fang RH; Zhang FR
Biomed Pharmacother; 2016 Oct; 83():1016-1021. PubMed ID: 27525969
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of elF3a inhibits TGF‑β1‑induced extracellular matrix protein expression in keloid fibroblasts.
Li T; Zhao J
Mol Med Rep; 2018 Mar; 17(3):4057-4061. PubMed ID: 29286129
[TBL] [Abstract][Full Text] [Related]
5. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach.
Wu CS; Wu PH; Fang AH; Lan CC
Br J Dermatol; 2012 Sep; 167(3):532-41. PubMed ID: 22540338
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of FOXM1 inhibits activation of keloid fibroblasts and extracellular matrix production via inhibition of TGF-β1/Smad pathway.
Zhang Y; Cheng C; Wang S; Xu M; Zhang D; Zeng W
Life Sci; 2019 Sep; 232():116637. PubMed ID: 31288014
[TBL] [Abstract][Full Text] [Related]
7. Halofuginone regulates keloid fibroblast fibrotic response to TGF-β induction.
Marty P; Chatelain B; Lihoreau T; Tissot M; Dirand Z; Humbert P; Senez C; Secomandi E; Isidoro C; Rolin G
Biomed Pharmacother; 2021 Mar; 135():111182. PubMed ID: 33433355
[TBL] [Abstract][Full Text] [Related]
8. Keloid fibroblasts are more sensitive to Wnt3a treatment in terms of elevated cellular growth and fibronectin expression.
Chua AW; Gan SU; Ting Y; Fu Z; Lim CK; Song C; Sabapathy K; Phan TT
J Dermatol Sci; 2011 Dec; 64(3):199-209. PubMed ID: 22005028
[TBL] [Abstract][Full Text] [Related]
9. ADAM17 regulates the proliferation and extracellular matrix of keloid fibroblasts by mediating the EGFR/ERK signaling pathway.
Le X; Fan YF
J Plast Surg Hand Surg; 2023; 57(1-6):129-136. PubMed ID: 34978504
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of fibronectin extra domain B suppresses TGF-β1-mediated cell proliferation and collagen deposition in keloid fibroblasts via AKT/ERK signaling pathway.
Cui J; Li Z; Jin C; Jin Z
Biochem Biophys Res Commun; 2020 Jun; 526(4):1131-1137. PubMed ID: 32317186
[TBL] [Abstract][Full Text] [Related]
11. Oleanolic acid regulates the proliferation and extracellular matrix of keloid fibroblasts by mediating the TGF-β1/SMAD signaling pathway.
Luo Y; Wang D; Yuan X; Jin Z; Pi L
J Cosmet Dermatol; 2023 Jul; 22(7):2083-2089. PubMed ID: 36847714
[TBL] [Abstract][Full Text] [Related]
12. Transmembrane protein 88 inhibits transforming growth factor-β1-induced-extracellular matrix accumulation and epithelial-mesenchymal transition program in human pleural mesothelial cells through modulating TGF-β1/Smad pathway.
Sun Z; Ning Q; Li H; Hu T; Tang L; Wen Q; Shen L
J Recept Signal Transduct Res; 2022 Feb; 42(1):60-66. PubMed ID: 33167758
[TBL] [Abstract][Full Text] [Related]
13. Decoy Wnt receptor (sLRP6E1E2)-expressing adenovirus induces anti-fibrotic effect via inhibition of Wnt and TGF-β signaling.
Lee WJ; Lee JS; Ahn HM; Na Y; Yang CE; Lee JH; Hong J; Yun CO
Sci Rep; 2017 Nov; 7(1):15070. PubMed ID: 29118355
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-708 modulates Hepatic Stellate Cells activation and enhances extracellular matrix accumulation via direct targeting TMEM88.
Xu T; Pan L; Li L; Hu S; Zhou H; Yang C; Yang J; Li H; Liu Y; Meng X; Li J
J Cell Mol Med; 2020 Jul; 24(13):7127-7140. PubMed ID: 32463570
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rg3 inhibits keloid fibroblast proliferation, angiogenesis and collagen synthesis in vitro via the TGF‑β/Smad and ERK signaling pathways.
Tang M; Bian W; Cheng L; Zhang L; Jin R; Wang W; Zhang Y
Int J Mol Med; 2018 Mar; 41(3):1487-1499. PubMed ID: 29328420
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin Is Involved in Connective Tissue Growth Factor-Induced Proliferation, Migration and Overproduction of the Extracellular Matrix in Keloid Fibroblasts.
Luo L; Li J; Liu H; Jian X; Zou Q; Zhao Q; Le Q; Chen H; Gao X; He C
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28498357
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide inhibits fibronectin production in TGF-β1-treated normal and keloid fibroblasts via inhibition of the p38/Smad3 pathway.
Liang CJ; Yen YH; Hung LY; Wang SH; Pu CM; Chien HF; Tsai JS; Lee CW; Yen FL; Chen YL
Biochem Pharmacol; 2013 Jun; 85(11):1594-602. PubMed ID: 23500539
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
Fang F; Huang RL; Zheng Y; Liu M; Huo R
J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
[TBL] [Abstract][Full Text] [Related]
19. TRAF3IP2 regulated by FOXO4 affects fibroblast proliferation, migration, and extracellular matrix deposition in keloid through the TGF-β1/Smad pathway.
Yan Q; Li B
J Cosmet Dermatol; 2022 Oct; 21(10):5148-5155. PubMed ID: 35441794
[TBL] [Abstract][Full Text] [Related]
20. Osteomodulin contributes to keloid development by regulating p38 MAPK signaling.
Li Q; Chen H; Liu Y; Bi J
J Dermatol; 2023 Jul; 50(7):895-905. PubMed ID: 37017425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]